Finding Immune Nascent Type 1 Diabetes

Finding Immune Nascent Type 1 Diabetes (FIND T1D)

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is:

What form of recruitment communication is most effective for completing a type 1diabetes home screening kit?

Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch).

Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.

Inclusion Criteria:

• Participant must be in Indiana Biobank
• Participant must be able to provide consent
• Ages 1-99 including pregnant women

Exclusion Criteria:

• Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study
• While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening